Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 21, Issue 1, 2003, Pages 87-90

  Sari, Refik A ^a   Taysi, Seyithan ^a   Yilmaz, Ömer ^a   Bakan, Nuri ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Isoenzymes; Rheumatoid arthritis

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE DEAMINASE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; ISOENZYME;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE;

ADENOSINE DEAMINASE; ADULT; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0037288107     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31; 315-24.
2. HARRIS ED: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990: 322; 1277-89.
3. HOCHBERG MC: Adult and juvenile rheumatoid arthritis: Current epidemiologic concepts. Epidemiol Rev 1981; 3: 27-44.
4. SARI RA, TAYSI S, ERDEM F et al.: Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus. Rheumatology Int 2002; 21: 149-52.
5. ADAMS A, HARKNESS RA: Adenosine deaminase activity in thymus and other human tissues. Clin Exp Immunol 1976; 26: 647-9.
6. MACDERMOTT RP, TRITSCH GL, FORMEISTER JF: Adenosine deaminase and nucleoside phosphorylase activities in normal human blood mononuclear cell populations. Clin Exp Immunol 1980; 42: 303-7.
7. SIMMONDS HA, PANAYI GS, CORRIGAL V: A role for purine metabolismin the immune response: Adenosine deaminase activity and deoxyadenosine catabolism. Lancet 1978; 1: 60.
8. COLLAZOS J, ESPANA P, MAYO J, MARTINEZ E, IZQUIRERDO F: Sequential evaluation of serum adenosine deaminase in patients treated for tuberculosis. Chest 1998; 114: 432-5.
9. CRONSTEIN BN, NAIME D, FIRESTEIN G: The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 1995; 38: 1040-5.
10. LE MOINE O, STORDEUR P, SCHANDANE L et al.: Adenosine enhances IL-10 secretion by human monocytes. 1996; 156: 4408-14.
11. SPYCHALA J: Tumor-promoting functions of adenosine. Pharmacol Ther 2000; 87: 161-73.
12. STANCIKOVA M, LUKAC J, ISTOK R, CRISTALLI G, ROVENSKY: Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16: 583-6.
13. RATECH H, MARTINIUK F, BORER WZ, RAPPOPORT H: Differential expression of adenosine deaminase isoenzymes in acute leukemia. Blood 1988; 72: 1627-32.
14. ZUCKERMAN SH, OLSON JM, DOUGLAS SD: Adenosine deaminase activity during in vitro culture of human peripheral blood monocytes and pulmonary alveolar macrophages. Exp Cell Res 1980; 129: 281-7.
15. MURAOKA T, KATSUMARAKI T, SHIRAISHI H, YOKOYAMA MT: Automated enzymatic measurement of adenosine deaminase isoenzyme activities in serum. Anal Biochem 1990; 187: 268-72.
16. DASMAHAPATRA KS, FACS MD, HILL HZ, DASMAHAPATRA A, SUAREZ S: Evaluation of adenosine deaminase activity in patients with head and neck cancer. J Surg Res 1986; 40: 368-73.
17. PKINS H, STANTON A, DAVIS BH: Adenosine deaminase activity in lymphoid subpopulations and leukemias. Cencer Res 1981; 41: 3107.
18. TUNG R, SILBER R, QUAGLIATA F, CONKLYN M, GOTTESMAN J, HISCHHORN R: Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J Clin Invest 1976; 57: 756-61.
19. YÜKSEL H, AKOGLU TF: Serum and synovial adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 1988; 47: 492-5.
20. MEUNIER P, FILIPE P, EMERIT I, FREITAS J, RODRIGO FG, MANSO C: Adenosine deaminase in progressive systemic sclerosis. Acta Derm Venerol (Stockh) 1995; 75: 297-9.
21. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
22. GUSTI G: Adenosine deaminase. In BERG MAYER HU (Ed.): Methods of Enzymatic Analysis, vol. 2, 2nd ed., New York, Academic Press 1974; 1092-4.
23. THOMPSON PW, JAMES IT, ROWELL L, JONES DD: Evaluation of a simple method for the measurement of cytidine deaminase in serum and comparison with reference method. Clin Chim Acta 1990; 192: 55-60.
24. HARTWICK R, JEFFRIES A, KRSTULOVIC A, BROWN PR: An optimized assay for adenosine deaminase isoenzyme using reverse phase high pressure liquid chromatography. J Chromat Sci 1978; 427: 427-35.
25. VAN DER HEIJDE DMFM, VAN'T HOF MA, VAN RIEL PLCM: Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990: 49: 916-20.
26. VAN RIEL PLCM, VAN GESTEL AM, VAN DE PUTTE LBA: Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996: 35 (Suppl. 2); 4-7.
27. CURREY HLF: Aetiology and pathogenesis of rheumatoid arthritis. In: Copeman's Textbook of the Rheumatic Diseases. Edinburgh, Churchill Livingstone 1978; 261-72.
28. APPELBOOM T, MANELBAUM I, VERTONGEN F: Purine enzyme levels in rheumatoid arthritis. J Rheumatol 1985; 12: 1075-78.
29. HITOGLOU S, HATZISTILIANOU M, GOUGOUSTAMOU D, ATHANASSIADOU F, KOTSIS A, CATRIU D: Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2001; 20: 411-16.
30. OOSTHUIZEN HM, UNGERER JP, BISSBORT SH: Kinetic determination of serum adenosine deaminase. Clin Chem 1993; 39: 2182-5.
31. NALINI G, HARIPRASAD C, CHANDRASEKARAN AN, POONGUZHALI K: A comparative study of serum deaminase in systemic rheumatic disease. Br J Rheumatol 1993; 32: 1118-9.
32. UNGERER JPL, OOSTHUIZEN HM, BISSBORT SH, VERMAAK WJH: Serum adenosine deaminase: Isoenzymes and diagnostic application. Clin Chem 1992; 38: 1322-6.
33. GAKIS C: Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: Diagnostic and biological role. Eur Respir J 1996; 9:632-3.
34. CORDERO OJ, SALGADO FJ, MERA-VARELA A, NOGUEIRA M: Serum interleukin-12, interleukin-15, soluble CD26,and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol Int 2001; 21: 69-74.
35. TAYSI S, POLAT MF, SARI RA, BAKAN E: Serum adenosine deaminase and cytidine deaminase activites in patients with systemic lupus erytematosus. Clin Chem Lab Med 2002; 40: 493-5.
36. CRONSTEIN BN, NAIME D, OSTAD E: The anti-inflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92: 2675-82.